Organization
Kobe University Graduate School of Medicine, Kobe, Japan
2 abstracts
Abstract
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody.Org: Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe-Shi, Japan, Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe-Shi Chuo-Ku, HYOGO-KEN, Japan, Kobe University Hospital, Kobe, Hyogo, Japan, Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Hyogo, Japan, Kansai Medical University Hospital, Hirakata-Shi, Japan,
Abstract
A NOVEL PHARMACOLOGICAL ACTION OF MTX THROUGH CIRCADIAN CLOCK GENES IN RA FIBROBLAST-LIKE SYNOVIAL CELLS Org: Biophysics, Kobe University Graduate School of Health Sciences, Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, KonanKakogawa Hospital, Kakogawa,